New Delhi, Oct. 17 -- Graph AI closed a $3 million Seed round led by Bessemer to scale Graph Safety - an AI-native platform that automates adverse event processing, signal detection and regulatory reporting in the $8B pharmacovigilance market.

Pharmacovigilance - the continuous monitoring of adverse drug events (ADEs) - is a regulatory necessity and a persistent operational headache for pharma companies. The work spans clinical trials to post-market surveillance and relies heavily on manual review of unstructured sources: call centre transcripts, legal filings, medical literature, emails and even social media posts. Historically, large service firms have shouldered this load with armies of trained reviewers, creating fragmented, slow and...